​
Login / Signup
Julie A Rhoades
(Julie A Sterling)
ORCID
Publication Activity (10 Years)
Years Active: 2018-2023
Publications (10 Years): 3
Top Topics
Patient Safety
Stem Cells
Iron Oxide
Adverse Drug
Top Venues
Cancer research communications
Journal of cellular biochemistry
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
David C Florian
,
Natalie E Bennett
,
Mateusz Odziomek
,
Jessalyn J Baljon
,
Mohamed Wehbe
,
Alyssa R Merkel
,
Melissa A Fischer
,
Michael R Savona
,
Julie A Rhoades
,
Scott A Guelcher
,
John Tanner Wilson
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
Cancer research communications
3 (2) (2023)
David C Florian
,
Natalie E Bennett
,
Mateusz Odziomek
,
Jessalyn J Baljon
,
Mohamed Wehbe
,
Alyssa R Merkel
,
Melissa A Fischer
,
Michael R Savona
,
Julie A Rhoades
,
Scott A Guelcher
,
John Tanner Wilson
Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction.
Cancer research communications
3 (2) (2023)
Joseph P Vanderburgh
,
Scott A Guelcher
,
Julie A Rhoades
3D bone models to study the complex physical and cellular interactions between tumor and the bone microenvironment.
Journal of cellular biochemistry
119 (7) (2018)